vs

Side-by-side financial comparison of ENANTA PHARMACEUTICALS INC (ENTA) and Outdoor Holding Co (POWW). Click either name above to swap in a different company.

ENANTA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($18.6M vs $13.4M, roughly 1.4× Outdoor Holding Co). Outdoor Holding Co runs the higher net margin — 16.7% vs -64.1%, a 80.8% gap on every dollar of revenue. On growth, ENANTA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.8% vs -54.1%). Outdoor Holding Co produced more free cash flow last quarter ($5.0M vs $-11.8M).

Enanta Pharmaceuticals Inc is a clinical-stage biotechnology company that develops innovative antiviral therapies for infectious diseases including hepatitis B virus, respiratory syncytial virus (RSV), and SARS-CoV-2. It operates primarily in the U.S. and global markets, partnering with pharmaceutical firms to advance its small molecule drug candidate pipeline for patients with unmet medical needs.

Vista Outdoor Inc. was an American designer, manufacturer, and marketer that operated in two segments: shooting sports and outdoor products. It was a "house of brands" with more than 40 labels and subsidiaries.

ENTA vs POWW — Head-to-Head

Bigger by revenue
ENTA
ENTA
1.4× larger
ENTA
$18.6M
$13.4M
POWW
Growing faster (revenue YoY)
ENTA
ENTA
+63.9% gap
ENTA
9.8%
-54.1%
POWW
Higher net margin
POWW
POWW
80.8% more per $
POWW
16.7%
-64.1%
ENTA
More free cash flow
POWW
POWW
$16.9M more FCF
POWW
$5.0M
$-11.8M
ENTA

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
ENTA
ENTA
POWW
POWW
Revenue
$18.6M
$13.4M
Net Profit
$-11.9M
$2.2M
Gross Margin
87.1%
Operating Margin
-60.5%
14.7%
Net Margin
-64.1%
16.7%
Revenue YoY
9.8%
-54.1%
Net Profit YoY
46.4%
108.5%
EPS (diluted)
$-0.42
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ENTA
ENTA
POWW
POWW
Q4 25
$18.6M
$13.4M
Q3 25
$15.1M
$12.0M
Q2 25
$18.3M
$11.9M
Q1 25
$14.9M
$12.6M
Q4 24
$17.0M
$12.5M
Q3 24
$14.6M
$12.0M
Q2 24
$18.0M
$12.3M
Q1 24
$17.1M
$-50.7M
Net Profit
ENTA
ENTA
POWW
POWW
Q4 25
$-11.9M
$2.2M
Q3 25
$-18.7M
$1.4M
Q2 25
$-18.3M
$-6.5M
Q1 25
$-22.6M
$-77.5M
Q4 24
$-22.3M
$-26.1M
Q3 24
$-28.8M
$-12.4M
Q2 24
$-22.7M
$-14.8M
Q1 24
$-31.2M
$-5.2M
Gross Margin
ENTA
ENTA
POWW
POWW
Q4 25
87.1%
Q3 25
87.1%
Q2 25
87.2%
Q1 25
87.5%
Q4 24
87.4%
Q3 24
86.9%
Q2 24
85.8%
Q1 24
Operating Margin
ENTA
ENTA
POWW
POWW
Q4 25
-60.5%
14.7%
Q3 25
-121.6%
5.9%
Q2 25
-103.2%
-50.7%
Q1 25
-164.3%
-213.6%
Q4 24
-138.8%
-163.8%
Q3 24
-204.4%
-50.3%
Q2 24
-134.6%
-50.8%
Q1 24
-192.1%
Net Margin
ENTA
ENTA
POWW
POWW
Q4 25
-64.1%
16.7%
Q3 25
-123.6%
11.7%
Q2 25
-99.7%
-54.5%
Q1 25
-151.7%
-614.5%
Q4 24
-131.4%
-208.7%
Q3 24
-197.3%
-103.7%
Q2 24
-126.1%
-120.2%
Q1 24
-182.7%
10.3%
EPS (diluted)
ENTA
ENTA
POWW
POWW
Q4 25
$-0.42
$0.01
Q3 25
$-0.88
$0.01
Q2 25
$-0.85
$-0.06
Q1 25
$-1.06
$-0.67
Q4 24
$-1.05
$-0.23
Q3 24
$-1.36
$-0.11
Q2 24
$-1.07
$-0.13
Q1 24
$-1.47
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ENTA
ENTA
POWW
POWW
Cash + ST InvestmentsLiquidity on hand
$37.4M
$69.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$126.6M
$237.3M
Total Assets
$329.5M
$271.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ENTA
ENTA
POWW
POWW
Q4 25
$37.4M
$69.9M
Q3 25
$32.3M
$65.7M
Q2 25
$44.8M
$63.4M
Q1 25
$60.2M
$30.2M
Q4 24
$84.3M
$31.9M
Q3 24
$37.2M
$33.5M
Q2 24
$35.8M
$50.8M
Q1 24
$63.5M
$55.6M
Stockholders' Equity
ENTA
ENTA
POWW
POWW
Q4 25
$126.6M
$237.3M
Q3 25
$64.7M
$235.4M
Q2 25
$79.3M
$222.5M
Q1 25
$93.5M
$222.0M
Q4 24
$111.8M
$299.6M
Q3 24
$128.8M
$325.6M
Q2 24
$148.9M
$342.5M
Q1 24
$166.1M
$358.0M
Total Assets
ENTA
ENTA
POWW
POWW
Q4 25
$329.5M
$271.7M
Q3 25
$280.7M
$270.3M
Q2 25
$301.0M
$269.5M
Q1 25
$323.0M
$297.3M
Q4 24
$348.6M
$355.4M
Q3 24
$376.7M
$368.9M
Q2 24
$398.8M
$398.6M
Q1 24
$413.6M
$403.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ENTA
ENTA
POWW
POWW
Operating Cash FlowLast quarter
$-11.7M
$5.7M
Free Cash FlowOCF − Capex
$-11.8M
$5.0M
FCF MarginFCF / Revenue
-63.6%
37.6%
Capex IntensityCapex / Revenue
0.8%
4.8%
Cash ConversionOCF / Net Profit
2.55×
TTM Free Cash FlowTrailing 4 quarters
$-18.5M
$-2.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ENTA
ENTA
POWW
POWW
Q4 25
$-11.7M
$5.7M
Q3 25
$-6.5M
$3.2M
Q2 25
$17.5M
$-6.7M
Q1 25
$-13.5M
$-1.5M
Q4 24
$-16.8M
$1.3M
Q3 24
$-10.4M
$-9.3M
Q2 24
$-14.8M
$-547.5K
Q1 24
$-28.6M
$4.3M
Free Cash Flow
ENTA
ENTA
POWW
POWW
Q4 25
$-11.8M
$5.0M
Q3 25
$-7.9M
$2.5M
Q2 25
$17.4M
$-7.6M
Q1 25
$-16.0M
$-2.3M
Q4 24
$-25.5M
$720.3K
Q3 24
$-19.4M
$-10.6M
Q2 24
$-21.3M
$-1.3M
Q1 24
$-30.3M
$1.4M
FCF Margin
ENTA
ENTA
POWW
POWW
Q4 25
-63.6%
37.6%
Q3 25
-52.5%
21.0%
Q2 25
94.7%
-63.8%
Q1 25
-107.4%
-18.6%
Q4 24
-150.6%
5.8%
Q3 24
-132.5%
-88.3%
Q2 24
-118.6%
-11.0%
Q1 24
-177.5%
-2.8%
Capex Intensity
ENTA
ENTA
POWW
POWW
Q4 25
0.8%
4.8%
Q3 25
9.6%
5.8%
Q2 25
0.8%
7.5%
Q1 25
17.0%
6.5%
Q4 24
51.6%
4.4%
Q3 24
61.3%
10.4%
Q2 24
36.4%
6.5%
Q1 24
9.8%
-5.7%
Cash Conversion
ENTA
ENTA
POWW
POWW
Q4 25
2.55×
Q3 25
2.29×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons